Relicalm 5 Tablet
By Relicalm
Rx
10 Tablet in a Strip

Composition
Trifluoperazine(5mg)

Manufacturer - Reliance Formulation Pvt Ltd
Reliance Formulation Private Limited, 201-202, Anand Mangal-3, Rajnagar Club Road Ambabadi, Ahmedabad-380015, Gujarat, India

Expires on or after
June, 2026

liver
Limited information is available regarding the use of Relicalm 5 Tablet in individuals with liver disease. It is advisable to consult a healthcare professional before taking this medication. Based on the available data, using Relicalm 5 Tablet is not recommended for patients with liver disease. Please seek medical advice before using this medication if you have any liver-related concerns.

kidney
Limited information exists on the use of Relicalm 5 Tablet in patients with kidney disease. Consult your doctor for guidance.

alcohol
When taking Relicalm 5 Tablet, be cautious as it can increase drowsiness when combined with alcohol.

driving
When taking Relicalm 5 Tablet, be cautious while driving as it may cause dizziness, drowsiness, or blurred vision, affecting your ability to drive safely.

pregnancy
Relicalm 5 Tablet is not recommended during pregnancy due to potential harm to the developing baby. Limited human studies show risks, while animal studies indicate harmful effects. Your doctor will assess benefits versus risks before prescribing. Consult your doctor for more information.

breastfeeding
Relicalm 5 Tablet is considered unsafe during breastfeeding as limited human data indicates the drug might pass into breastmilk, potentially harming the baby.
Habit Forming | No |
Chemical Class | Phenothiazine Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Typical Antipsychotics |
₹15
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025